3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
361
Precursor Cell Lymphoblastic Leukemia-Lymphoma
328
Lymphoma
297
Leukemia
254
Multiple Myeloma
246
Leukemia, Myeloid, Acute
241
Lymphoma, Non-Hodgkin
240
Lymphoma, Large B-Cell, Diffuse
238
Leukemia, Lymphocytic, Chronic, B-Cell
220
Myelodysplastic Syndromes
184
Lymphoma, Follicular
176
Hodgkin Disease
165
Lymphoma, Mantle-Cell
163
Burkitt Lymphoma
160
Lymphoma, B-Cell, Marginal Zone
117
Recurrence
115
Lymphoma, Large-Cell, Immunoblastic
95
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Myeloproliferative Disorders
81
Melanoma
78
Neoplasms, Plasma Cell
77
Leukemia, Myeloid, Chronic-Phase
72
Hematologic Neoplasms
72
Leukemia, Myeloid, Accelerated Phase
71
Leukemia, Myelomonocytic, Chronic
69
Lymphoma, B-Cell
65
Dendritic Cell Sarcoma, Interdigitating
64
Triple Negative Breast Neoplasms
63
Ovarian Neoplasms
61
Congenital Abnormalities
59
Interventions
Diathermy
20
Radiotherapy
11
Fluorouracil
4
Drug Therapy
4
Cisplatin
4
Radiation
3
Immune Checkpoint Inhibitors
3
Brachytherapy
3
tislelizumab
2
Surgical Procedures, Operative
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Conization
2
Capecitabine
2
spartalizumab
1
anlotinib
1
Temozolomide
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Ifosfamide
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gemcitabine
1
Folfox protocol
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hyperthermia
×
Cyclophosphamide
×
Clear all
NCT03749850
2021-02-17
i-GO
UMC Utrecht
Phase 1
Unknown
12 enrolled